LH Stock May Gain From Select MAWD Pathology Asset Purchase Deal [Yahoo! Finance]
Labcorp Holdings Inc. (LH)
Last labcorp holdings inc. earnings: 4/29 06:53 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=84636&p=irol-irhome
Company Research
Source: Yahoo! Finance
Labcorp has entered into an agreement with MAWD Pathology Group to acquire select assets of its clinical and women's health testing businesses. This acquisition is expected to provide patients, physicians, and customers with greater access to Labcorp's high-quality laboratory services and expanded testing capabilities in communities across Kansas City and the surrounding region. According to the article, 'Labcorp continues to execute its strategic priorities well by being a partner of choice for health systems and regional local laboratories, leveraging science and innovation to expand leadership in important therapeutic areas and utilizing data and technology to bring important services and capabilities to the customers.' Was this helpful? Yes No How does Labcorp's stock rank compared to other medical stocks and what are some alternative investment options? Labcorp currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the broader medical space are Penumbra
Show less
Read more
Impact Snapshot
Event Time:
LH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LH alerts
High impacting Labcorp Holdings Inc. news events
Weekly update
A roundup of the hottest topics
LH
News
- Labcorp Launches H5 Bird Flu Test Amid US Outbreak: Stock to Gain? [Yahoo! Finance]Yahoo! Finance
- Laboratory Co. of America Holdings (NYSE: LH) had its price target raised by analysts at Morgan Stanley from $260.00 to $270.00. They now have an "overweight" rating on the stock.MarketBeat
- Lip Injection Market to hit USD 5.95 billion by 2032, says Global Market Insights Inc. [Yahoo! Finance]Yahoo! Finance
- Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians [Yahoo! Finance]Yahoo! Finance
- Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through PhysiciansPR Newswire
LH
Earnings
- 10/24/24 - Beat
LH
Sec Filings
- 12/4/24 - Form 4
- 12/4/24 - Form 4
- 12/4/24 - Form 4
- LH's page on the SEC website